Effect of Curcumin on Lung Inflammation
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Change in sputum dysplasia
We evaluated presence of moderate or worse dysplasia at baseline and each subsequent visits. The primary endpoint of this study is change in sputum cytological abnormality (moderate or worse dysplasia). The change will be comparison of 3-month follow up compared to baseline.
3 months
No
United States: Institutional Review Board
H-17419
NCT01514266
April 2005
August 2010
Name | Location |
---|---|
VA Medical Center | Houston, Texas 77030 |